Information Provided By:
Fly News Breaks for March 4, 2020
Mar 4, 2020 | 07:58 EDT
Craig-Hallum analyst Jason Kreyer downgraded Cardlytics to Hold from Buy with a price target of $70, down from $100. The analyst notes that some operational missteps combined with a rapidly deteriorating macro yielded a substantial miss relative to Q1 estimates. The economic environment is "quite challenging" as consumer purchasing trends have tapered substantially due to the coronavirus, and the duration of this impact is impossible to predict, he adds.
News For CDLX From the Last 2 Days
Apr 15, 2021 | 06:45 EDT
Wells Fargo analyst Timothy Willi upgraded Cardlytics to Overweight from Equal Weight with a $150 price target. Willi believes the recent underperformance has created a favorable entry point for shares, and sees several fundamental catalysts over the near to medium term, the analyst tells investors in a research note. The analyst views the risk/reward as favorable at current levels and the liquidity position as stable.